KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.44%
Dec 31, 2025 16.08%
Sep 30, 2025 3.98%
Jun 30, 2025 61.52%
Mar 31, 2025 37.75%
Dec 31, 2024 15.61%
Sep 30, 2024 -1.69%
Jun 30, 2024 4.04%
Mar 31, 2024 -56.44%
Dec 31, 2023 9.96%
Sep 30, 2023 1.42%
Jun 30, 2023 49.19%
Mar 31, 2023 10.40%
Dec 31, 2022 23.14%
Sep 30, 2022 17.27%
Jun 30, 2022 12.30%
Mar 31, 2022 -1.83%
Dec 31, 2021 26.65%
Sep 30, 2021 7.18%
Jun 30, 2021 -0.65%
Mar 31, 2021 13.50%
Dec 31, 2020 -96.31%
Sep 30, 2020 27.50%
Jun 30, 2020 12.09%
Mar 31, 2020 -22.76%
Dec 31, 2019 -61.99%
Sep 30, 2019 13.33%
Jun 30, 2019 36.51%
Mar 31, 2019 12.98%
Dec 31, 2018 10.22%
Sep 30, 2018 20.68%
Jun 30, 2018 -11.85%
Mar 31, 2018 18.84%
Dec 31, 2017 -36.15%
Sep 30, 2017 24.71%
Jun 30, 2017 -6.07%
Mar 31, 2017 -1.03%
Dec 31, 2016 -11.22%
Sep 30, 2016 -5.03%
Jun 30, 2016 -4.69%
Mar 31, 2016 -5.30%
Dec 31, 2015 23.50%
Sep 30, 2015 -16.26%
Jun 30, 2015 -18.13%
Mar 31, 2015 -0.83%
Dec 31, 2014 -15.03%
Sep 30, 2014 49.25%
Jun 30, 2014 -20.27%
Mar 31, 2014 287.88%